Omland, Torbjørn

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

SCORE2 working group and ESC Cardiovascular risk collaboration, Hageman, S., Pennells, L., Ojeda, F., Kaptoge, S., Kuulasmaa, K., de Vries, T., Xu, Z., Kee, F., Chung, R., et al. (2021) · European Heart Journal

Health Promotion and Cardiovascular PreventionCardiovascular Health and Risk Factors

Cited by 1,810

A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk

Williams, S. A., Ostroff, R., Hinterberg, M. A., Coresh, J., Ballantyne, C. M., Matsushita, K., Mueller, C. E., Walter, J., Jonasson, C., Holman, R. R., et al. (2022) · Science Translational Medicine

Lipoproteins and Cardiovascular HealthCardiovascular Health and Risk Factors

Cited by 97

Prognostic Usefulness of Circulating High-Sensitivity Troponin T in Aortic Stenosis and Relation to Echocardiographic Indexes of Cardiac Function and Anatomy

Røsjø, H., Andreassen, J., Edvardsen, T., & Omland, T. (2011) · The American Journal of Cardiology

Cardiac Valve Diseases and TreatmentsAcute Myocardial Infarction Research

Cited by 83

Prognostic Value of Circulating MicroRNA-210 Levels in Patients with Moderate to Severe Aortic Stenosis

Røsjø, H., Dahl, M. B., Bye, A., Andreassen, J., Jørgensen, M., Wisløff, U., Christensen, G., Edvardsen, T., & Omland, T. (2014) · PLoS ONE

MicroRNA in disease regulationCardiac Valve Diseases and Treatments

Cited by 41

Predictors of coronary atherosclerosis in middle-aged and older athletes: the MARC-2 study

Berge, K., Janssen, S. L. J. E., Velthuis, B. K., Myhre, P. L., Mosterd, A., Omland, T., Eijsvogels, T. M. H., & Aengevaeren, V. L. (2025) · European Heart Journal - Cardiovascular Imaging

Cardiovascular Effects of ExerciseCardiac Imaging and Diagnostics

Cited by 11